» Articles » PMID: 25980492

Deregulation of Focal Adhesion Pathway Mediated by MiR-659-3p is Implicated in Bone Marrow Infiltration of Stage M Neuroblastoma Patients

Abstract

To get insights on the metastatic process of human neuroblastoma (NB), the miRNA expression profile of bone marrow (BM)-infiltrating cells has been determined and compared to that of primary tumors.Twenty-two BM-infiltrating cells, 22 primary tumors, and 4 paired samples from patients with metastatic NB aged > 12 months were analyzed for the expression of 670 miRNAs by stem-loop RT-qPCR. The miRNAs whose expression was significantly different were subjected to selection criteria, and 20 selected miRNAs were tested in 10 additional BM-infiltrating cells and primary tumors. Among the miRNAs confirmed to be differentially expressed, miR-659-3p was further analyzed. Transfection of miR-659-3p mimic and inhibitor demonstrated the specific suppression and over-expression, respectively, of the miR-659-3p target gene CNOT1, a regulator of transcription of genes containing AU-rich element (ARE) sequence. Among the ARE-containing genes, miR-659-3p mimic and inhibitor specifically modified the expression of AKT3, BCL2, CYR61 and THSB2, belonging to the focal adhesion pathway. Most importantly, in BM-infiltrating cells CNOT1 expression was significantly higher, and that of AKT3, BCL2, THSB2 and CYR61 was significantly lower than in primary tumors. Thus, our study suggests a role of the focal adhesion pathway, regulated by miR-659-3p through CNOT1, in the human NB metastatic process.

Citing Articles

RON receptor tyrosine kinase as a critical determinant in promoting tumorigenic behaviors of bladder cancer cells through regulating MMP12 and HIF-2α pathways.

Wang K, Ye S, Jia X, Wang K, Meng X, Fei X Cell Death Dis. 2024; 15(11):844.

PMID: 39557851 PMC: 11574271. DOI: 10.1038/s41419-024-07245-w.


Bone Marrow Environment in Metastatic Neuroblastoma.

Brignole C, Pastorino F, Perri P, Amoroso L, Bensa V, Calarco E Cancers (Basel). 2021; 13(10).

PMID: 34069335 PMC: 8158729. DOI: 10.3390/cancers13102467.


Non-Coding RNAs Participate in the Pathogenesis of Neuroblastoma.

Rezaei O, Tamizkar K, Hajiesmaeili M, Taheri M, Ghafouri-Fard S Front Oncol. 2021; 11:617362.

PMID: 33718173 PMC: 7945591. DOI: 10.3389/fonc.2021.617362.


Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma.

Marengo B, Pulliero A, Corrias M, Leardi R, Farinini E, Fronza G J Pers Med. 2021; 11(2).

PMID: 33562297 PMC: 7916079. DOI: 10.3390/jpm11020107.


Microvesicles expressing adenosinergic ectoenzymes and their potential role in modulating bone marrow infiltration by neuroblastoma cells.

Morandi F, Marimpietri D, Horenstein A, Corrias M, Malavasi F Oncoimmunology. 2019; 8(5):e1574198.

PMID: 31069133 PMC: 6492972. DOI: 10.1080/2162402X.2019.1574198.


References
1.
Corrias M, Haupt R, Carlini B, Cappelli E, Giardino S, Tripodi G . Multiple target molecular monitoring of bone marrow and peripheral blood samples from patients with localized neuroblastoma and healthy donors. Pediatr Blood Cancer. 2011; 58(1):43-9. DOI: 10.1002/pbc.22960. View

2.
Maris J . Recent advances in neuroblastoma. N Engl J Med. 2010; 362(23):2202-11. PMC: 3306838. DOI: 10.1056/NEJMra0804577. View

3.
Silver J, Ritchie M, Smyth G . Microarray background correction: maximum likelihood estimation for the normal-exponential convolution. Biostatistics. 2008; 10(2):352-63. PMC: 2648902. DOI: 10.1093/biostatistics/kxn042. View

4.
Green D, Galluzzi L, Kroemer G . Cell biology. Metabolic control of cell death. Science. 2014; 345(6203):1250256. PMC: 4219413. DOI: 10.1126/science.1250256. View

5.
Vandewoestyne M, Kumps C, Swerts K, Menten B, Lammens T, Philippe J . Isolation of disseminated neuroblastoma cells from bone marrow aspirates for pretreatment risk assessment by array comparative genomic hybridization. Int J Cancer. 2011; 130(5):1098-108. DOI: 10.1002/ijc.26133. View